WO2008114501A1 - 癌の診断薬及び治療薬 - Google Patents
癌の診断薬及び治療薬 Download PDFInfo
- Publication number
- WO2008114501A1 WO2008114501A1 PCT/JP2008/000586 JP2008000586W WO2008114501A1 WO 2008114501 A1 WO2008114501 A1 WO 2008114501A1 JP 2008000586 W JP2008000586 W JP 2008000586W WO 2008114501 A1 WO2008114501 A1 WO 2008114501A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- cancer
- diagnostic
- therapeutic agent
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
癌を診断および治療する新規方法を提供すること。
抗HNT抗体を含有する癌の診断薬および治療薬。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-068053 | 2007-03-16 | ||
JP2007068053A JP2010133705A (ja) | 2007-03-16 | 2007-03-16 | 癌の診断薬及び治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008114501A1 true WO2008114501A1 (ja) | 2008-09-25 |
Family
ID=39765620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/000586 WO2008114501A1 (ja) | 2007-03-16 | 2008-03-14 | 癌の診断薬及び治療薬 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2010133705A (ja) |
WO (1) | WO2008114501A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5794511B2 (ja) * | 2010-08-31 | 2015-10-14 | 国立大学法人 東京大学 | オートタキシン測定による膵疾患の検査方法および検査薬 |
WO2024024565A1 (ja) * | 2022-07-28 | 2024-02-01 | 国立大学法人 東京大学 | ニューロトリミンの機能阻害剤 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535806A (ja) * | 2001-06-27 | 2004-12-02 | キャンサー・リサーチ・テクノロジー・リミテッド | 癌 |
DE102004042822A1 (de) * | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
JP2006136323A (ja) * | 1998-03-10 | 2006-06-01 | Genentech Inc | 新規なポリペプチド及びそれをコードする核酸 |
-
2007
- 2007-03-16 JP JP2007068053A patent/JP2010133705A/ja active Pending
-
2008
- 2008-03-14 WO PCT/JP2008/000586 patent/WO2008114501A1/ja active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006136323A (ja) * | 1998-03-10 | 2006-06-01 | Genentech Inc | 新規なポリペプチド及びそれをコードする核酸 |
JP2004535806A (ja) * | 2001-06-27 | 2004-12-02 | キャンサー・リサーチ・テクノロジー・リミテッド | 癌 |
DE102004042822A1 (de) * | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
Non-Patent Citations (2)
Title |
---|
EVANGELOS NTOUGKOS ET AL.: "The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates", HUMAN CANCER BIOLOGY, vol. 11, no. 16, 15 August 2005 (2005-08-15), pages 5764 - 5768, XP003027705, DOI: doi:10.1158/1078-0432.CCR-04-2388 * |
ORLANDO D. GIL ET AL.: "Complementary expression and heterophilic interactions between IgLON family members Neurotrimin and LAMP", NEUROTRIMIN AND LAMP, J. NEUROBIOL., vol. 51, no. 3, 2002, pages 190 - 204 * |
Also Published As
Publication number | Publication date |
---|---|
JP2010133705A (ja) | 2010-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008153705A3 (en) | Methods of treating, diagnosing and detecting fgf21-associated disorders | |
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
EP2103628A4 (en) | MONOCLONAL ANTIBODY ANTI-CLAUDIN 3, AND TREATMENT AND DIAGNOSIS OF CANCER USING SUCH ANTIBODY | |
WO2007081720A3 (en) | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer | |
WO2006011810A3 (en) | Mr imaging method for the discrimination between healthy and tumour tissue | |
WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
WO2009108860A8 (en) | Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders | |
WO2006085906A3 (en) | Method for the direct detection of diagnostic rna | |
EP1922326A4 (en) | BIOMARKERS USEFUL FOR DIAGNOSING PROSTATE CANCER AND METHOD OF USE THEREOF | |
WO2007135546A3 (en) | TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES | |
WO2010025414A3 (en) | Diagnostics and treatments for vegf-independent tumors | |
WO2007047408A3 (en) | Promac signature application | |
WO2007118214A3 (en) | Antibody compositions and methods for treatment of neoplastic disease | |
WO2007115045A3 (en) | Diagnostics and treatments for tumors | |
WO2009083009A3 (en) | Monoclonal antibodies against cd32b | |
PT1949285T (pt) | Sistemas e métodos para tratamento, diagnóstico e previsão da ocorrência de uma condição médica | |
IL191538A0 (en) | Method for diagnosing, prognosing and treating glioma | |
EP1742654A4 (en) | ANTI-LFL2 ANTIBODIES FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER | |
WO2011015333A3 (en) | Targeting of bone marrow neovasculature | |
WO2007053284A3 (en) | Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor | |
EP2564864B8 (en) | FGF2-related methods for diagnosing and treating depression | |
WO2007123722A3 (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
WO2010009171A3 (en) | Src activation for determining cancer prognosis and as a target for cancer therapy | |
WO2007092444A3 (en) | Method and apparatus for dynamically correlating neurological and cardiovascular parameters and for diagnosing and treating patients using the same | |
WO2010054377A3 (en) | Fully human antibodies against n-cadherin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08720472 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08720472 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |